Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 758358, 14 pages
http://dx.doi.org/10.1155/2015/758358
Research Article

Cardiac H2S Generation Is Reduced in Ageing Diabetic Mice

1Shanghai Key Laboratory of Bioactive Small Molecules and Research Center on Aging and Medicine, Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai 200032, China
2Department of Physiology, Hebei Medical University, Hebei 050017, China
3Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 201203, China

Received 22 October 2014; Revised 5 January 2015; Accepted 5 January 2015

Academic Editor: Guangdong Yang

Copyright © 2015 Sheng Jin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin et al., “Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?” Endocrine Reviews, vol. 30, no. 1, pp. 96–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Johnson, T. Nakagawa, L. G. Sanchez-Lozada et al., “Sugar, uric acid, and the etiology of diabetes and obesity,” Diabetes, vol. 62, no. 10, pp. 3307–3315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Bray and B. M. Popkin, “Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar,” Diabetes Care, vol. 37, no. 4, pp. 950–956, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Koh-Banerjee, Y. Wang, F. B. Hu, D. Spiegelman, W. C. Willett, and E. B. Rimm, “Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men,” American Journal of Epidemiology, vol. 159, no. 12, pp. 1150–1159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Rubler, J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman, “New type of cardiomyopathy associated with diabetic glomerulosclerosis,” The American Journal of Cardiology, vol. 30, no. 6, pp. 595–602, 1972. View at Publisher · View at Google Scholar · View at Scopus
  6. T. L. Croston, D. Thapa, A. A. Holden et al., “Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart,” American Journal of Physiology. Heart and circulatory physiology, vol. 307, no. 1, pp. H54–H65, 2014. View at Publisher · View at Google Scholar
  7. A. Monji, T. Mitsui, Y. K. Bando, M. Aoyama, T. Shigeta, and T. Murohara, “Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 3, pp. H295–H304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-S. Beaudoin, C. G. R. Perry, A. M. Arkell et al., “Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats,” The Journal of Physiology, vol. 592, no. 12, pp. 2519–2533, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Pan, Y. Wang, Y. Zhao et al., “Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy,” Diabetes, vol. 63, no. 10, pp. 3497–3511, 2014. View at Publisher · View at Google Scholar
  10. T. O. Stølen, M. A. Høydal, O. J. Kemi et al., “Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy,” Circulation Research, vol. 105, no. 6, pp. 527–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zeng, X. He, X. Hou, L. Li, and J.-X. Chen, “Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 4, pp. H585–H597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Kabil, V. Vitvitsky, P. Xie, and R. Banerjee, “The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues,” Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 363–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Singh, D. Padovani, R. A. Leslie, T. Chiku, and R. Banerjee, “Relative contributions of cystathionine β-synthase and γ-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions,” Journal of Biological Chemistry, vol. 284, no. 33, pp. 22457–22466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Chiku, D. Padovani, W. Zhu, S. Singh, V. Vitvitsky, and R. Banerjee, “H2S biogenesis by human cystathionine γ-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia,” The Journal of Biological Chemistry, vol. 284, no. 17, pp. 11601–11612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Xu, Z. Liu, and P. Liu, “Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis,” International Journal of Cardiology, vol. 172, no. 2, pp. 313–317, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Takano, Y.-J. Peng, G. K. Kumar et al., “Hypoxia-inducible factors regulate human and rat cystathionine beta-synthase gene expression,” Biochemical Journal, vol. 458, no. 2, pp. 203–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara, and H. Kimura, “Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide,” Journal of Biochemistry, vol. 146, no. 5, pp. 623–626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Shibuya, S. Koike, M. Tanaka et al., “A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells,” Nature Communications, vol. 4, article 1366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. King, D. J. Polhemus, S. Bhushan et al., “Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 8, pp. 3182–3187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-L. Yao, X.-W. Huang, Y.-G. Wang, Y.-X. Cao, C.-C. Zhang, and Y.-C. Zhu, “Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1310–H1319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. M. Bos, R. Wang, P. M. Snijder et al., “Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress,” Journal of the American Society of Nephrology, vol. 24, no. 5, pp. 759–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Wen, D. Qi, Y. Sun et al., “H2S attenuates cognitive deficits through Akt1/JNK3 signaling pathway in ischemic stroke,” Behavioural Brain Research, vol. 269, pp. 6–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Zhou, Y. Cao, G. Ao et al., “Camkkbeta-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on Neuroinflammation,” Antioxidants & Redox Signaling, vol. 21, no. 12, pp. 1741–1758, 2014. View at Publisher · View at Google Scholar
  24. S. K. Jain, R. Bull, J. L. Rains et al., “Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?” Antioxidants and Redox Signaling, vol. 12, no. 11, pp. 1333–1338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Qi, Y. Zhou, Y. Xiao et al., “Promoter demethylation of cystathionine-β-synthetase gene contributes to inflammatory pain in rats,” Pain, vol. 154, no. 1, pp. 34–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. J. Lee, M. M. Mariappan, D. Feliers et al., “Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells,” Journal of Biological Chemistry, vol. 287, no. 7, pp. 4451–4461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. K. Jain, P. Manna, D. Micinski et al., “In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress?” Antioxidants and Redox Signaling, vol. 18, no. 10, pp. 1154–1158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Shen, Z. Shen, L. Miao et al., “miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression,” Antioxidants & Redox Signaling, vol. 22, no. 3, pp. 224–240, 2015. View at Publisher · View at Google Scholar
  29. M. Liang, S. Jin, D. Wu, M. Wang, and Y. Zhu, “Hydrogen sulfide improves glucose metabolism and prevents hypertrophy in cardiomyocytes,” Nitric Oxide, 2014. View at Publisher · View at Google Scholar
  30. X. Shen, C. B. Pattillo, S. Pardue, S. C. Bir, R. Wang, and C. G. Kevil, “Measurement of plasma hydrogen sulfide in vivo and in vitro,” Free Radical Biology and Medicine, vol. 50, no. 9, pp. 1021–1031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. G. A. Bray, S. J. Nielsen, and B. M. Popkin, “Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity,” The American Journal of Clinical Nutrition, vol. 79, no. 4, pp. 537–543, 2004. View at Google Scholar · View at Scopus
  32. M. Hokayem, E. Blond, H. Vidal et al., “Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients,” Diabetes Care, vol. 36, no. 6, pp. 1454–1461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. W. Zarich, B. E. Arbuckle, L. R. Cohen, M. Roberts, and R. W. Nesto, “Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed doppler echocardiography,” Journal of the American College of Cardiology, vol. 12, no. 1, pp. 114–120, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. J. P. Piccini, L. Klein, M. Gheorghiade, and R. O. Bonow, “New insights into diastolic heart failure: role of diabetes mellitus,” The American Journal of Medicine, vol. 116, no. 5, supplement 1, pp. 64–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Nielsen, S. B. Kristiansen, R. Nørregaard et al., “Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice,” European Journal of Heart Failure, vol. 11, no. 7, pp. 638–647, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Dong and J. Ren, “Fidarestat improves cardiomyocyte contractile function in db/db diabetic obese mice through a histone deacetylase Sir2-dependent mechanism,” Journal of Hypertension, vol. 25, no. 10, pp. 2138–2147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Wang, Q. Yang, Y.-Y. Sun et al., “Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice,” Journal of Cellular and Molecular Medicine, vol. 18, no. 8, pp. 1599–1611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Suarez, B. Scott, and W. H. Dillmann, “Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 295, no. 5, pp. R1439–R1445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. W. Younce, M. A. Burmeister, and J. E. Ayala, “Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a,” The American Journal of Physiology—Cell Physiology, vol. 304, no. 6, pp. C508–C518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Masuda, S. Muto, G. Fujisawa et al., “Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 9, pp. H1871–H1883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Guo, F. Liang, W. Shah Masood, and X. Yan, “Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway,” European Journal of Pharmacology, vol. 725, no. 1, pp. 70–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-H. Zhang, J. Hu, Y.-L. Zhou et al., “Promoted interaction of nuclear factor-κB with demethylated cystathionine-β-synthetase gene contributes to gastric hypersensitivity in diabetic rats,” Journal of Neuroscience, vol. 33, no. 21, pp. 9028–9038, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M.-J. Wang, W.-J. Cai, N. Li, Y.-J. Ding, Y. Chen, and Y.-C. Zhu, “The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia,” Antioxidants and Redox Signaling, vol. 12, no. 9, pp. 1065–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. W.-J. Cai, M.-J. Wang, P. K. Moore, H.-M. Jin, T. Yao, and Y.-C. Zhu, “The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation,” Cardiovascular Research, vol. 76, no. 1, pp. 29–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Whiteman, K. M. Gooding, J. L. Whatmore et al., “Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide,” Diabetologia, vol. 53, no. 8, pp. 1722–1726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Brancaleone, F. Roviezzo, V. Vellecco, L. de Gruttola, M. Bucci, and G. Cirino, “Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice,” British Journal of Pharmacology, vol. 155, no. 5, pp. 673–680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Zhang, G. Yang, G. Tang, L. Wu, and R. Wang, “Rat pancreatic level of cystathionine gamma-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation,” Diabetologia, vol. 54, no. 10, pp. 2615–2625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Bucci, V. Vellecco, A. Cantalupo et al., “Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition,” Cardiovascular Research, vol. 102, no. 1, pp. 138–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. E. P. Wijekoon, B. Hall, S. Ratnam, M. E. Brosnan, S. H. Zeisel, and J. T. Brosnan, “Homocysteine metabolism in ZDF (Type 2) diabetic rats,” Diabetes, vol. 54, no. 11, pp. 3245–3251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Oron-Herman, T. Rosenthal, and B.-A. Sela, “Hyperhomocysteinemia as a component of syndrome X,” Metabolism: Clinical and Experimental, vol. 52, no. 11, pp. 1491–1495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Fang, D. Zhang, Z. Cheng et al., “Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis,” Diabetes, vol. 63, no. 12, pp. 4275–4290, 2014. View at Publisher · View at Google Scholar
  52. P. Manna, N. Gungor, R. McVie, and S. K. Jain, “Decreased cystathionine-gamma-lyase (CSE) activity in livers of type 1 diabetic rats and peripheral blood mononuclear cells (PBMC) of type 1 diabetic patients,” Journal of Biological Chemistry, vol. 289, no. 17, pp. 11767–11778, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Kundu, S. B. Pushpakumar, A. Tyagi, D. Coley, and U. Sen, “Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9,” The American Journal of Physiology. Endocrinology and Metabolism, vol. 304, no. 12, pp. E1365–E1378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Yamamoto, W. Sato, T. Kosugi et al., “Distribution of hydrogen sulfide (H2S)-producing enzymes and the roles of the H2S donor sodium hydrosulfide in diabetic nephropathy,” Clinical and Experimental Nephrology, vol. 17, no. 1, pp. 32–40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Suzuki, G. Olah, K. Modis et al., “Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 33, pp. 13829–13834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Yusuf, B. T. K. Huat, A. Hsu, M. Whiteman, M. Bhatia, and P. K. Moore, “Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis,” Biochemical and Biophysical Research Communications, vol. 333, no. 4, pp. 1146–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Yang, G. Tang, L. Zhang, L. Wu, and R. Wang, “The pathogenic role of cystathionine γ-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice,” American Journal of Pathology, vol. 179, no. 2, pp. 869–879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Zhong, L. Wang, Y. Wang et al., “Exogenous hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial protection,” Molecular and Cellular Biochemistry, vol. 371, no. 1-2, pp. 187–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Kaneko, T. Kimura, S. Taniguchi et al., “Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose,” FEBS Letters, vol. 583, no. 2, pp. 377–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Kaneko, Y. Kimura, H. Kimura, and I. Niki, “L-cysteine inhibits insulin release from the pancreatic β-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter,” Diabetes, vol. 55, no. 5, pp. 1391–1397, 2006. View at Publisher · View at Google Scholar · View at Scopus